Aprea Therapeutics Inc

NASDAQ:APRE   4:00:00 PM EDT
6.69
+0.62 (+10.21%)
6:43:27 PM EDT: $6.50 -0.19 (-2.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aprea Therapeutics Inc Stock, NASDAQ:APRE

3805 Old Easton Road, Doylestown, Pennsylvania 18902
United States of America
Phone: +1.617.463.9385
Number of Employees: 9

Description

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.